View graph of relations
  1. 2015
  2. Published
    ten Have, M., Fidder, H. H., Leenders, M., Kaptein, A. A., van der Valk, M. E., van Bodegraven, A. A., ... Oldenburg, B. (2015). Self-reported Disability in Patients with Inflammatory Bowel Disease Largely Determined by Disease Activity and Illness Perceptions. Inflammatory Bowel Diseases, 21(2), 369-377. https://doi.org/10.1097/MIB.0000000000000278
  3. Published
    Derikx, L. A., Nissen, L. H., Drenth, J. P., van Herpen, C. M., Kievit, W., Verhoeven, R. H., ... Hoentjen, F. (2015). Better survival of renal cell carcinoma in patients with inflammatory bowel disease. Oncotarget. https://doi.org/10.18632/oncotarget.5186
  4. Published
    van der Valk, M. E., Mangen, M. J., Severs, M., ten Have, M., Dijkstra, G., van Bodegraven, A. A., ... Oldenburg, B. (2015). Comparison of Costs and Quality of Life in Ulcerative Colitis Patients with an Ileal Pouch-Anal Anastomosis, Ileostomy and Anti-TNFα Therapy. Journal of Crohn's & Colitis, 9(11), 1016-1023. https://doi.org/10.1093/ecco-jcc/jjv134
  5. Published
  6. Published
  7. Published
    Coenen, M. J., de Jong, D. J., van Marrewijk, C. J., Derijks, L. J., Vermeulen, S. H., Wong, D. R., ... Franke, B. (2015). Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease. Gastroenterology, 149(4), 907-917 e907. https://doi.org/10.1053/j.gastro.2015.06.002
  8. Published
  9. Published
    de Groof, E. J., Buskens, C. J., Ponsioen, C. Y., Dijkgraaf, M. G., D'Haens, G. R., Srivastava, N., ... Bemelman, W. A. (2015). Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial. Trials, 16(1), [366]. https://doi.org/10.1186/s13063-015-0831-x
  10. Published
  11. 2014
  12. Published
  13. Published
  14. Published
  15. Published
    Wong, D. R., Pierik, M., Seinen, M. L., van Bodegraven, A. A., Gilissen, L. P. L., Bus, P., ... Hooymans, P. M. (2014). The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Journal of Crohn's & Colitis, 8(2), 120-128. https://doi.org/10.1016/j.crohns.2013.07.004
  16. Published
  17. Published
  18. Published
  19. Published
    van der Have, M. M., Mangen, M. J., van der Valk, M. E., Smeets, H. M., van Bodegraven, A., Dijkstra, G., ... Oldenburg, B. (2014). Effect of Aging on Healthcare Costs of Inflammatory Bowel Disease: A Glimpse into the Future. Inflammatory Bowel Diseases, 20(4), 637-645. https://doi.org/10.1097/01.MIB.0000442677.55051.03
  20. Published
  21. Published
    van der Valk, M. E., Mangen, M. J., Leenders, M., Dijkstra, G., van Bodegraven, A. A., Fidder, H. H., ... Oldenburg, B. (2014). Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study. Gut, 63(1), 72-79. https://doi.org/10.1136/gutjnl-2012-303376
  22. 2013
  23. Published
  24. Published
  25. Published
    Flourie, B., Hagege, H., Tucat, G., Maetz, D., Hebuterne, X., Kuyvenhoven, J. P., ... Aoucheta, D. (2013). Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis. Alimentary Pharmacology & Therapeutics, 37(8), 767-775. https://doi.org/10.1111/apt.12266
  26. Published
    van Schaik, F. D., Mooiweer, E., ten Have, M., Belderbos, T. D., ten Kate, F. J., Offerhaus, G. J., ... Oldenburg, B. (2013). Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia. Inflammatory Bowel Diseases, 19(2), 342-349. https://doi.org/10.1097/MIB.0b013e318286f771
  27. Published
  28. Published
  29. 2012
  30. Published
  31. Published
  32. Published
  33. 2011
  34. Published
  35. Published
    Katsanos, K. H., Tatsioni, A., Pedersen, N., Shuhaibar, M., Ramirez, V. H., Politi, P., ... Tsianos, E. V. (2011). Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. Journal of Crohn's & Colitis, 5(5), 430-442. https://doi.org/10.1016/j.crohns.2011.04.013
  36. Published
    Vos, A. C., Bakkal, N., Minnee, R. C., Casparie, M. K., de Jong, D. J., Dijkstra, G., ... Hommes, D. W. (2011). Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study. Inflammatory Bowel Diseases, 17(9), 1837-1845. https://doi.org/10.1002/ibd.21582
  37. Published
  38. Published
    Baars, J. E., Kuipers, E. J., Dijkstra, G., Hommes, D. W., de Jong, D. J., Stokkers, P. C., ... van der Woude, C. J. (2011). Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands. Scandinavian Journal of Gastroenterology, 46(3), 319-325. https://doi.org/10.3109/00365521.2010.536251
  39. Published
    Zelinkova, Z., de Haar, C., De Ridder, L., Pierik, M. J., Kuipers, E. J., Peppelenbosch, M. P., & van der Woude, C. J. (2011). High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Alimentary Pharmacology & Therapeutics, 33(9), 1053-1058. https://doi.org/10.1111/j.1365-2036.2011.04617.x
  40. 2010
  41. Published
  42. 2009
  43. Published
  44. Published
    Bodelier, A. G., Heijckmann, C., Hameeteman, W., De Boer, E., Jonkers, D. M. A. E., Masclee, A. A. M., & Pierik, M. J. (2009). Bone Mineral Density in IBD: A 5-Year Follow-Up Study. Gastroenterology, 136(5), A196-A196.
  45. Published
    Bueno de Mesquita, M., Ferrante, M., Henckaerts, L., Joossens, M., Janssens, V., Hlavaty, T., ... Hoffman, I. (2009). Clustering of (auto)immune diseases with early-onset and complicated inflammatory bowel disease. European Journal of Pediatrics, 168(5), 575-583. https://doi.org/10.1007/s00431-008-0798-7
  46. Published
  47. 2007
  48. Published
  49. Published
    Ferrante, M., Henckaerts, L., Joossens, M., Pierik, M. J., Joossens, S., Dotan, N., ... Vermeire, S. (2007). New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut, 56(10), 1394-1403. https://doi.org/10.1136/gut.2006.108043
  50. Published
  51. Published
  52. 2005
  53. Published
    Pierik, M. J., de Hertogh, G., Vermeire, S., van Assche, G., van Eyken, P., Joossens, S., ... Geboes, K. (2005). Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn's disease. Gut, 54(2), 223-227. https://doi.org/10.1136/gut.2004.042572
  54. Published
Previous 1 2 Next